NCT03730064View on ClinicalTrials.gov

Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar Depression

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions
Bipolar DisorderDepression
Interventions
DRUG

N-acetyl cysteine (NAC)

Experimental medication with N-acetyl cysteine (NAC) for six weeks

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
lead

Martin Lan

OTHER

NCT03730064 - Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar Depression | Biotech Hunter | Biotech Hunter